Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Epipharyngeal abrasive therapy (EAT)

  • Open Access
    Epipharyngeal Abrasive Therapy Down-regulates the Expression of Cav1.2: A Key Molecule in Influenza Virus Entry
    KENSUKE NISHI, SHOHEI YOSHIMOTO, SOICHIRO NISHI, TATSURO NISHI, RYUSHIRO NISHI, TOSHIYUKI TSUNODA, HIROMITSU MORITA, HIROAKI TANAKA, OSAMU HOTTA, SUSUMU YASUMASU, KENJI HIROMATSU, SENJI SHIRASAWA, TAKASHI NAKAGAWA and TAKAFUMI YAMANO
    In Vivo September 2022, 36 (5) 2357-2364; DOI: https://doi.org/10.21873/invivo.12967
In Vivo

© 2026 In Vivo

Powered by HighWire